These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 28079114)

  • 1. Discovering potential serological biomarker for chronic Hepatitis B Virus-related hepatocellular carcinoma in Chinese population by MAL-associated serum glycoproteomics analysis.
    Liu T; Liu D; Liu R; Jiang H; Yan G; Li W; Sun L; Zhang S; Liu Y; Guo K
    Sci Rep; 2017 Jan; 7():38918. PubMed ID: 28079114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble Axl Is a Novel Diagnostic Biomarker of Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection.
    Song X; Wu A; Ding Z; Liang S; Zhang C
    Cancer Res Treat; 2020 Jul; 52(3):789-797. PubMed ID: 32138467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High levels of serum Mac-2-binding protein glycosylation isomer (M2BPGi) predict the development of hepatocellular carcinoma in hepatitis B patients treated with nucleot(s)ide analogues.
    Shinkai N; Nojima M; Iio E; Matsunami K; Toyoda H; Murakami S; Inoue T; Ogawa S; Kumada T; Tanaka Y
    J Gastroenterol; 2018 Jul; 53(7):883-889. PubMed ID: 29288305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Online Calculator Based on Serum Biomarkers to Detect Hepatocellular Carcinoma among Patients with Hepatitis B.
    Yang T; Xing H; Wang G; Wang N; Liu M; Yan C; Li H; Wei L; Li S; Fan Z; Shi M; Chen W; Cai S; Pawlik TM; Soh A; Beshiri A; Lau WY; Wu M; Zheng Y; Shen F
    Clin Chem; 2019 Dec; 65(12):1543-1553. PubMed ID: 31672853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-associated carbohydrate antigens as potential biomarkers for hepatocellular carcinoma.
    Wu CS; Yen CJ; Chou RH; Li ST; Huang WC; Ren CT; Wu CY; Yu YL
    PLoS One; 2012; 7(7):e39466. PubMed ID: 22808038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection.
    Deng H; Fan X; Wang X; Zeng L; Zhang K; Zhang X; Li N; Han Q; Lv Y; Liu Z
    Sci Rep; 2020 Nov; 10(1):20276. PubMed ID: 33219288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of an Autoantibody Panel and Alpha-Fetoprotein for Early Detection of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Shen Y; Chen J; Wu J; Li T; Yi C; Wang K; Wang P; Sun C; Ye H
    Cancer Prev Res (Phila); 2024 May; 17(5):227-235. PubMed ID: 38489403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study.
    Shen Q; Fan J; Yang XR; Tan Y; Zhao W; Xu Y; Wang N; Niu Y; Wu Z; Zhou J; Qiu SJ; Shi YH; Yu B; Tang N; Chu W; Wang M; Wu J; Zhang Z; Yang S; Gu J; Wang H; Qin W
    Lancet Oncol; 2012 Aug; 13(8):817-26. PubMed ID: 22738799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of glycoprotein capture-based label-free method for the high-throughput screening of differential glycoproteins in hepatocellular carcinoma.
    Chen R; Tan Y; Wang M; Wang F; Yao Z; Dong L; Ye M; Wang H; Zou H
    Mol Cell Proteomics; 2011 Jul; 10(7):M110.006445. PubMed ID: 21474793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Mac-2 binding protein glycosylation isomer level predicts hepatocellular carcinoma development in E-negative chronic hepatitis B patients.
    Mak LY; To WP; Wong DK; Fung J; Liu F; Seto WK; Lai CL; Yuen MF
    World J Gastroenterol; 2019 Mar; 25(11):1398-1408. PubMed ID: 30918432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urine α-fetoprotein and orosomucoid 1 as biomarkers of hepatitis B virus-associated hepatocellular carcinoma.
    Zhan Z; Guan Y; Mew K; Zeng W; Peng M; Hu P; Yang Y; Lu Y; Ren H
    Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G305-G312. PubMed ID: 31736338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of 5 serum biomarkers for hepatocellular carcinoma with different epidemiological backgrounds: A large-scale, retrospective study.
    Liu D; Luo Y; Chen L; Chen L; Zuo D; Li Y; Zhang X; Wu J; Xi Q; Li G; Qi L; Yue X; Zhang X; Sun Z; Zhang N; Song T; Lu W; Guo H
    Cancer Biol Med; 2021 Feb; 18(1):256-270. PubMed ID: 33628599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma.
    Yao M; Zhao J; Lu F
    Oncotarget; 2016 Jan; 7(4):3702-8. PubMed ID: 26784252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma.
    Mao L; Wang Y; Wang D; Han G; Fu S; Wang J
    PLoS One; 2017; 12(9):e0183880. PubMed ID: 28902891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypomethylation of the cyclin D1 promoter in hepatitis B virus-associated hepatocellular carcinoma.
    Liu HH; Fang Y; Wang JW; Yuan XD; Fan YC; Gao S; Han LY; Wang K
    Medicine (Baltimore); 2020 May; 99(20):e20326. PubMed ID: 32443384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.
    Ji J; Wang H; Li Y; Zheng L; Yin Y; Zou Z; Zhou F; Zhou W; Shen F; Gao C
    PLoS One; 2016; 11(4):e0153227. PubMed ID: 27070780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of inflammatory score/liver function and AFP improves the diagnostic accuracy of HBV-related hepatocellular carcinoma.
    Ding Y; Liu K; Xu Y; Zhao Q; Lou S; Xiang X; Yan L; Cao Z; Xie Q; Zhu C; Bao S; Wang H
    Cancer Med; 2020 May; 9(9):3057-3069. PubMed ID: 32150664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA MyD88 functions as a promising diagnostic biomarker in hepatocellular carcinoma.
    Wang Z; Gao P; Sun W; Rehman AU; Jiang J; Xu S; Xue C; Zhu C; Qin X
    Front Endocrinol (Lausanne); 2023; 14():938102. PubMed ID: 36793272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum 90K/MAC-2BP glycoprotein in patients with liver cirrhosis and hepatocellular carcinoma: a comparison with alpha-fetoprotein.
    Iacovazzi PA; Trisolini A; Barletta D; Elba S; Manghisi OG; Correale M
    Clin Chem Lab Med; 2001 Oct; 39(10):961-5. PubMed ID: 11758611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Diagnostic Value of Serum PIVKA-II Alone or in Combination with AFP in Chinese Hepatocellular Carcinoma Patients.
    Xu F; Zhang L; He W; Song D; Ji X; Shao J
    Dis Markers; 2021; 2021():8868370. PubMed ID: 33628341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.